TNFRSF1A | Tumor necrosis factor receptor superfamily, member 1A | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
SCNN1A | Sodium channel, non-voltage-gated 1 alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
LTBR | Lymphotoxin beta receptor (TNFR superfamily, member 3) | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD27 | CD27 molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
TAPBPL | TAP binding protein-like | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
VAMP1 | Vesicle-associated membrane protein 1 (synaptobrevin 1) | FDA approved drug targets Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
MRPL51 | Mitochondrial ribosomal protein L51 | Mitochondrial proteins
| | | | | Expressed in all |
NCAPD2 | Non-SMC condensin I complex, subunit D2 | Plasma proteins
| | | | | Expressed in all |
GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | Enzymes Plasma proteins
| | | | | Expressed in all |
IFFO1 | Intermediate filament family orphan 1 | | | | | | Expressed in all |
NOP2 | NOP2 nucleolar protein | Plasma proteins
| | | | | Expressed in all |
CHD4 | Chromodomain helicase DNA binding protein 4 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
LPAR5 | Lysophosphatidic acid receptor 5 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
ACRBP | Acrosin binding protein | Predicted secreted proteins
| | | | | Tissue enriched |
ING4 | Inhibitor of growth family, member 4 | | | | | | Expressed in all |
ZNF384 | Zinc finger protein 384 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
PIANP | PILR alpha associated neural protein | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COPS7A | COP9 signalosome subunit 7A | | | | | | Expressed in all |
MLF2 | Myeloid leukemia factor 2 | | | | | | Expressed in all |
PTMS | Parathymosin | | | | | | Expressed in all |
LAG3 | Lymphocyte-activation gene 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD4 | CD4 molecule | CD markers FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
GPR162 | G protein-coupled receptor 162 | G-protein coupled receptors Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GNB3 | Guanine nucleotide binding protein (G protein), beta polypeptide 3 | Plasma proteins RAS pathway related proteins
| | | | | Mixed |
CDCA3 | Cell division cycle associated 3 | | | | | | Mixed |
USP5 | Ubiquitin specific peptidase 5 (isopeptidase T) | Enzymes Plasma proteins
| | | | | Expressed in all |
TPI1 | Triosephosphate isomerase 1 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
SPSB2 | SplA/ryanodine receptor domain and SOCS box containing 2 | | | | | | Expressed in all |
LRRC23 | Leucine rich repeat containing 23 | | | | | | Group enriched |
ENO2 | Enolase 2 (gamma, neuronal) | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins
| | | | | Expressed in all |
ATN1 | Atrophin 1 | Disease related genes Plasma proteins
| | | | | Expressed in all |
C12orf57 | Chromosome 12 open reading frame 57 | Disease related genes
| | | | | Expressed in all |
PTPN6 | Protein tyrosine phosphatase, non-receptor type 6 | Enzymes Plasma proteins
| | | | | Expressed in all |
EMG1 | EMG1 N1-specific pseudouridine methyltransferase | | | | | | Expressed in all |
PHB2 | Prohibitin 2 | Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
LPCAT3 | Lysophosphatidylcholine acyltransferase 3 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
C1S | Complement component 1, s subcomponent | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
C1R | Complement component 1, r subcomponent | Predicted secreted proteins
| | | | | Expressed in all |
C1RL | Complement component 1, r subcomponent-like | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
RBP5 | Retinol binding protein 5, cellular | Plasma proteins
| | | | | Tissue enhanced |
CLSTN3 | Calsyntenin 3 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
PEX5 | Peroxisomal biogenesis factor 5 | Disease related genes
| | | | | Expressed in all |
ACSM4 | Acyl-CoA synthetase medium-chain family member 4 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Not detected |
CD163L1 | CD163 molecule-like 1 | CD markers Predicted membrane proteins
| | | | | Mixed |
CD163 | CD163 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
APOBEC1 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 | | | | | | Group enriched |
GDF3 | Growth differentiation factor 3 | Disease related genes Predicted secreted proteins
| | | | | Not detected |
DPPA3 | Developmental pluripotency associated 3 | | | | | | Not detected |
CLEC4C | C-type lectin domain family 4, member C | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
NANOGNB | NANOG neighbor homeobox | Transcription factors
| | | | | Not detected |